The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed ...

Amtivo Group, a global leader in certification services, is pleased to announce the successful acquisition of US-based certification body, Audit3. This strategic move, completed in December 2024, ...

AnaptysBio, Inc. ( NASDAQ:ANAB ) shareholders should be happy to see the share price up 13% in the last month. But ...